drugset / Trial / NCT07112144
Adsorption of Cell-free Diphtheria and Tetanus (Three-component) Combined With Vaccine Phase III Clinical Trial
Phase 3
Recruiting
1650 enrolled
Changchun BCHT Biotechnology Co.
Guizhou Provincial Center for Disease Control and Prevention · collabShaanxi Provincial Center for Disease Control and Prevention · collabShandong Provincial Center for Disease Control and Prevention · collabYunnan Provincial Center for Disease Control and Prevention · collab
RandomizedParallel-groupQuadruple-blindPrevention
Summary
The immunogenicity and safety of the adsorption of cell-free diphtheria and tetanus (three-component) combined vaccine were evaluated at 2 months, 4 months and 6 months.
Timeline
- Start
- 2025-06-13
- Primary completion
- 2032-06
- Completion
- 2032-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | DTaP | Vaccine | 0.5 ml | Other |
| Subject | DTacP | Vaccine | 0.5 ml | Other |
| Comparator | DTacP-IPV/Hib | Vaccine | 0.5 ml | Other |